Hasil Pencarian - Wei-Wu Ye

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2− Breast Cancer Patient With High Tumor Mutational Burden

    Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2āˆ’ Breast Cancer Patient With High Tumor Mutational Burden oleh Rong Wang, Rong Wang, Yuchen Yang, Wei-Wu Ye, Wei-Wu Ye, Jianxing Xiang, Songan Chen, Wei-Bin Zou, Wei-Bin Zou, Xiao-Jia Wang, Xiao-Jia Wang, Tianhui Chen, Tianhui Chen, Wen-Ming Cao, Wen-Ming Cao

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer

    Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349ā€‰Cā€‰>ā€‰G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer oleh Ziyan Yang, Jianguo Feng, Ji Jing, Yuan Huang, Wei-Wu Ye, Lei Lei, Xiao-Jia Wang, Wen-Ming Cao

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China

    AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China oleh Jia-Ni Pan, Pu-Chun Li, Meng Wang, Ming-Wei Li, Xiao-Wen Ding, Tao Zhou, Hui-Na Wang, Yun-Kai Wang, Li-Bin Chen, Rong Wang, Wei-Wu Ye, Wei-Zhu Wu, Feng Lou, Xiao-Jia Wang, Wen-Ming Cao

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: